ConductScience.org, home

Library / Trial comparisons

Chronic HF Without SDB vs Chronic HF With SDB: Digitalis

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.1950.1820.208wilsonClinicalTrials.gov
Risk in group 20.1880.1750.202wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.00675-0.01190.0253newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 21.040.941.14logClinicalTrials.gov
Odds ratio, group 1 over group 21.040.9261.18logClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on Chronic HF Without SDB than on Chronic HF With SDB148from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Chronic HF Without SDB
Patients with chronic heart failure (left ventricular ejection fraction ≤45% or New York Heart Association (NYHA) class III or IV or NYHA class II with ≥1 hospitalization within 12 months before inclusion) and no sleep disordered breathing (SDB, Apnoea-Hypopnoea Index AHI ≥15)
7173,686OG000ClinicalTrials.gov
Group 2Chronic HF With SDB
Patients with chronic heart failure (left ventricular ejection fraction ≤45% or New York Heart Association (NYHA) class III or IV or NYHA class II with ≥1 hospitalization within 12 months before inclusion) and sleep disordered breathing (SDB, Apnoea-Hypopnoea Index AHI ≥15)
5993,190OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleDigitalisClinicalTrials.gov
DescriptionClinicalTrials.gov
Time frame1-time: At baseline medication was assessed 1 time (anamnesis)ClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleSleep-Disordered Breathing in Heart Failure - The SchlaHF-RegistryClinicalTrials.gov
NCT numberNCT01500759ClinicalTrials.gov
PhasesClinicalTrials.gov
ConditionsCongestive Heart Failure, Left Ventricular Systolic DysfunctionClinicalTrials.gov
InterventionsClinicalTrials.gov
Lead sponsorResMedClinicalTrials.gov
Results first posted2020-07-09ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT01500759?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.